description
Powered by Eupheria Biotech
Quality Level
product line
MISSION®
form
lyophilized powder
esiRNA cDNA target sequence
TCCAACACCCTCAACTTTCAGATCAGCGAAGTGGAGCCCAAATACTATGCAGATGGGGAAGATGCGTATGCAATGAAGCGGGACCTCACGCAGATGGCTGATGAGCTGAGGCGGCACCTGGAGCTGAAGGAAAAGGGCAAGCACATGGTTCTGGCGGCCTTGGAGAACAAAGCGGAGAACAAAGGCAACGTGCTTCTGAGCTCAGGAGAGGCCTGTCGTGAGGAGAAGGGCCTGGCTGCTGAGGATAGTGGTGGGGACAGCAAGGACCTCAGTGAGGTCAGCGAGACCACAGAGAGCACAGATGTCAAAGACAGCTCAGAGGCCTCTGACTCTGCCTCCTAGAACCTGCCCCACCTGGTCCCAACCTTGCCCCATGTGCTTTTACAATAAATGTCACCCAGTGGCC
Ensembl | mouse accession no.
NCBI accession no.
shipped in
ambient
storage temp.
−20°C
Gene Information
mouse ... ARD1A(56292), Ard1a(56292)
General description
MISSION® esiRNA are endoribonuclease prepared siRNA. They are a heterogeneous mixture of siRNA that all target the same mRNA sequence. These multiple silencing triggers lead to highly-specific and effective gene silencing.
For additional details as well as to view all available esiRNA options, please visit SigmaAldrich.com/esiRNA.
For additional details as well as to view all available esiRNA options, please visit SigmaAldrich.com/esiRNA.
Legal Information
MISSION is a registered trademark of Merck KGaA, Darmstadt, Germany
存储类别
10 - Combustible liquids
flash_point_f
Not applicable
flash_point_c
Not applicable
法规信息
新产品
此项目有
Line M Myklebust et al.
Human molecular genetics, 24(7), 1956-1976 (2014-12-10)
The X-linked lethal Ogden syndrome was the first reported human genetic disorder associated with a mutation in an N-terminal acetyltransferase (NAT) gene. The affected males harbor an Ser37Pro (S37P) mutation in the gene encoding Naa10, the catalytic subunit of NatA
全球贸易项目编号
| 货号 | GTIN |
|---|---|
| EMU003661-20UG | 04061828655151 |
| EMU003661-50UG | 04061828430109 |